Craft

Eden Research

Stock Price

£0

2024-10-29

Market Capitalization

£229.3 K

2024-08-23

Revenue

£4.3 M

FY, 2024

Eden Research Summary

Company Summary

Overview
Eden Research PLC Eden Research plc is an AIM-listed public company with intellectual property and expertise in microencapsulation, terpenes and environmentally friendly technologies. We are developing these technologies through innovative research and a series of appropriate commercial production, marketing and distribution partnerships. Based in Cirencester in the UK, we are developing natural solutions to agricultural, animal, human health and industrial problems, with our primary focus being the use of terpenes to create an exciting array of low-risk but effective agricultural chemicals. Eden's products take advantage of the biocidal efficacy of naturally occurring chemicals produced by plant defence mechanisms and, in particular, the antimicrobial properties of terpenes. Terpenes are naturally occurring, low-toxicity botanical substances produced by most plants as part of their defence mechanisms. The initial Eden approach has involved the use of GRAS substances, that is, compounds 'Generally Recogised As Safe' for human consumption or application to food crops. Board of Directors: - Tom Lupton, Non-executive Chairman - Sean Smith, Chief Executive Officer - Alexander John Abrey, Chief Financial Officer - Robin Cridland, Non-executive Director Company No. 03071324
Type
Public
Status
Active
Founded
1996
HQ
Milton, GB | view all locations
Website
http://www.edenresearch.com/
Cybersecurity rating
Sectors

Key People

  • Sean Smith

    Sean Smith, CEO

    • Lykele van der Broek, Non-Executive Chairman

      • Alex Abrey

        Alex Abrey, CFO

        • Robin Cridland, Non-Executive Director

          LocationsView all

          1 location detected

          • Milton, England HQ

            United Kingdom

            Milton Park Innovation Centre, 99 Park Dr

          Eden Research Financials

          Summary Financials

          Revenue (H1, 2025)
          £1.2M
          Gross profit (H1, 2025)
          £799.0K
          Net income (H1, 2025)
          (£1.3M)
          Cash (H1, 2025)
          £1.8M
          EBIT (H1, 2025)
          (£1.7M)
          Enterprise value
          ($1.0M)

          Footer menu